X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-18 | EYPT | Eyepoint Pharmaceuticals, Inc. | Cormorant Asset Management, LP | 10% | P - Purchase | $18.03 | +581,765 | 7,475,000 | +8% | +$10,489,446 | ||||||
2024-04-15 | FEIM | Frequency Electronics Inc | Sarachek Russell M | Dir | P - Purchase | $9.77 | +658 | 433,745 | 0% | +$6,429 | ||||||
2024-04-16 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $40.00 | -1,451 | 999,782 | 0% | -$58,040 | ||||||
| M | 2024-04-16 | NPCE | Neuropace Inc | Orbimed Advisors LLC | 10% | S - Sale | $14.02 | -16,992 | 3,501,975 | 0% | -$238,231 | |||||
| D | 2024-04-17 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $95.12 | -4,000 | 543,446 | -1% | -$380,480 | |||||
2024-04-17 | INSP | Inspire Medical Systems, Inc. | Buchholz Richard | CFO | S - Sale | $230.03 | -15,000 | 30,471 | -33% | -$3,450,450 | ||||||
| D | 2024-04-17 | AXDX | Accelerate Diagnostics, Inc | Phillips Jack | CEO | S - Sale+OE | $0.78 | -26,735 | 162,919 | -14% | -$20,853 | |||||
2024-04-16 | TRMB | Trimble Inc. | Large Peter | SVP | S - Sale | $59.10 | -1,447 | 8,220 | -15% | -$85,518 | ||||||
2024-04-16 | TRMB | Trimble Inc. | Schwartz Mark David | SVP, CES | S - Sale | $59.10 | -2,322 | 10,265 | -18% | -$137,230 | ||||||
2024-04-17 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.03 | +15,363 | 15,284,431 | 0% | +$15,801 | ||||||
2024-04-15 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $15.67 | -10,000 | 129,644 | -7% | -$156,700 | ||||||
2024-04-15 | PETV | Petvivo Holdings, Inc. | Lai John | CEO, Pres | P - Purchase | $0.60 | +150,000 | 1,288,592 | +13% | +$90,000 | ||||||
| D | 2024-04-15 | AERG | Applied Energetics, Inc. | Adamczyk Bradford Thomas | Exec COB | S - Sale+OE | $1.78 | -10,000 | 2,235,081 | 0% | -$17,760 | |||||
| D | 2024-04-15 | TRMB | Trimble Inc. | Schwartz Mark David | SVP, CES | S - Sale+OE | $61.14 | -235 | 12,587 | -2% | -$14,368 | |||||
2024-04-15 | SONX | Sonendo, Inc. | Guo Chris | Interim CFO | S - Sale | $0.08 | -481 | 51,506 | -1% | -$39 | ||||||
| D | 2024-04-12 | NARI | Inari Medical, Inc. | Hill, Mitch C. | CFO | S - Sale+OE | $40.96 | -6,000 | 182,894 | -3% | -$245,760 | |||||
2024-04-15 | DXCM | Dexcom Inc | Dolan Matthew Vincent | EVP Strategy, Corporate Dev | S - Sale | $137.81 | -1,990 | 42,377 | -4% | -$274,242 | ||||||
| D | 2024-04-12 | AXDX | Accelerate Diagnostics, Inc | Phillips Jack | CEO | S - Sale+OE | $0.86 | -26,545 | 129,726 | -17% | -$22,829 | |||||
2024-04-15 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.06 | +3,587 | 15,269,068 | 0% | +$3,802 | ||||||
2024-04-15 | COHR | Coherent Corp. | Mattera Vincent D Jr | CEO | S - Sale | $53.10 | -5,000 | 669,684 | -1% | -$265,483 | ||||||
2024-04-11 | BVS | Bioventus Inc. | Singleton Mark Leonard | SVP, CFO | S - Sale | $4.75 | -4,000 | 34,665 | -10% | -$19,000 | ||||||
2024-04-11 | BVS | Bioventus Inc. | D'Adamio Anthony | SVP, GC | S - Sale | $4.75 | -3,054 | 58,242 | -5% | -$14,507 | ||||||
2024-04-11 | BVS | Bioventus Inc. | Church Katrina J | SVP, Chief Compliance Officer | S - Sale | $4.75 | -1,325 | 17,042 | -7% | -$6,294 | ||||||
| M | 2024-04-11 | NPCE | Neuropace Inc | Orbimed Advisors LLC | 10% | S - Sale | $14.49 | -485,000 | 3,518,967 | -12% | -$7,026,033 | |||||
| D | 2024-04-02 | MOVE | Movano Inc. | Caballero Ruben | Dir | P - Purchase | $0.00 | +22,000 | 80,200 | +38% | +$0 | |||||
| D | 2024-04-10 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $95.09 | -12,000 | 543,446 | -2% | -$1,141,080 | |||||
2024-04-09 | CTKB | Cytek Biosciences, Inc. | Yan Ming | CTO | S - Sale | $7.00 | -1,900 | 6,008,502 | 0% | -$13,304 | ||||||
| DM | 2024-04-09 | INTT | Intest Corp | Grant Richard N. Jr. | Pres, CEO | S - Sale+OE | $12.27 | -63,500 | 171,717 | -27% | -$779,305 | |||||
2024-04-09 | TRMB | Trimble Inc. | Painter Robert G | Pres, CEO | S - Sale | $62.50 | -3,500 | 228,901 | -2% | -$218,750 | ||||||
| M | 2024-03-26 | KEQU | Kewaunee Scientific Corp /de/ | Noble Ryan S. | VP-Sales, Marketing-Americas | S - Sale | $33.24 | -750 | 10,985 | -6% | -$24,930 | |||||
| D | 2024-04-08 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $100.47 | -59,801 | 101,845 | -37% | -$6,008,359 | |||||
| D | 2024-04-09 | AXDX | Accelerate Diagnostics, Inc | Patience David | CFO | S - Sale+OE | $0.87 | -13,296 | 51,179 | -21% | -$11,568 | |||||
| D | 2024-04-09 | AXDX | Accelerate Diagnostics, Inc | Mertz Larry Michael | CTO | S - Sale+OE | $0.87 | -13,984 | 81,106 | -15% | -$12,166 | |||||
| DM | 2024-04-08 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $90.35 | -19,900 | 51,012 | -28% | -$1,798,002 | |||||
2024-04-08 | DXCM | Dexcom Inc | Sayer Kevin R | Pres CEO, COB | S - Sale | $138.30 | -49,633 | 283,893 | -15% | -$6,864,136 | ||||||
| M | 2024-04-05 | GKOS | Glaukos Corp | Thurman Alex R. | SVP, CFO | S - Sale | $99.91 | -1,634 | 52,532 | -3% | -$163,260 | |||||
| D | 2024-04-05 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $96.81 | -2,457 | 101,845 | -2% | -$237,862 | |||||
| D | 2024-04-09 | EW | Edwards Lifesciences Corp | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $92.34 | -857 | 17,488 | -5% | -$79,135 | |||||
2024-04-08 | MDT | Medtronic Plc | Marinaro Michael | EVP, Pres, Surgical OU | S - Sale | $83.14 | -854 | 27,925 | -3% | -$71,002 | ||||||
| D | 2024-04-08 | EW | Edwards Lifesciences Corp | Lemercier Jean-Luc M | CVP, EMEACLA | S - Sale+OE | $92.32 | -14,400 | 173,849 | -8% | -$1,329,472 | |||||
| D | 2024-04-08 | EW | Edwards Lifesciences Corp | Bobo Donald E Jr | CVP,Strategy, Corp Development | S - Sale+OE | $92.33 | -12,500 | 213,465 | -6% | -$1,154,142 | |||||
2024-04-08 | ANGO | Angiodynamics Inc | Clemmer James C | Pres, CEO | P - Purchase | $6.70 | +10,000 | 539,066 | +2% | +$67,000 | ||||||
| M | 2024-04-02 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.10 | +42,044 | 15,265,481 | 0% | +$46,383 | |||||
| DM | 2024-04-03 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $96.59 | -400 | 101,845 | 0% | -$38,636 | |||||
| M | 2024-04-03 | GKOS | Glaukos Corp | Thurman Alex R. | SVP, CFO | S - Sale | $95.03 | -750 | 54,166 | -1% | -$71,271 | |||||
| DM | 2024-04-03 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $80.21 | -10,000 | 51,012 | -16% | -$802,084 | |||||
| D | 2024-04-04 | AXDX | Accelerate Diagnostics, Inc | Mertz Larry Michael | CTO | S - Sale+OE | $0.88 | -978 | 54,457 | -2% | -$861 | |||||
| D | 2024-04-04 | AXDX | Accelerate Diagnostics, Inc | Phillips Jack | CEO | S - Sale+OE | $0.88 | -15,887 | 96,343 | -14% | -$13,981 | |||||
| M | 2024-04-02 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Pres, Commercial Ops | S - Sale | $15.53 | -4,227 | 251,533 | -2% | -$65,652 | |||||
2024-04-02 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $15.45 | -2,425 | 205,516 | -1% | -$37,474 | ||||||
2024-04-03 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale | $5.08 | -4,893 | 168,620 | -3% | -$24,852 | ||||||
2024-04-03 | SGHT | Sight Sciences, Inc. | Badawi Paul | Pres, CEO | S - Sale | $5.08 | -12,571 | 5,750,729 | 0% | -$63,848 | ||||||
2024-04-03 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $5.08 | -3,128 | 1,762,776 | 0% | -$15,887 | ||||||
2024-04-03 | SGHT | Sight Sciences, Inc. | Park Sam Boong | COO | S - Sale | $5.08 | -3,414 | 261,754 | -1% | -$17,340 | ||||||
2024-04-03 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | CFO | S - Sale | $5.08 | -10,123 | 426,248 | -2% | -$51,415 | ||||||
| D | 2024-04-04 | EW | Edwards Lifesciences Corp | Mussallem Michael A | Dir | S - Sale+OE | $92.42 | -29,350 | 4,042,863 | -1% | -$2,712,418 | |||||
| D | 2024-04-02 | MOVE | Movano Inc. | Cogan Jeremy | CFO | P - Purchase | $0.00 | +45,000 | 780,649 | +6% | +$0 | |||||
| D | 2024-04-02 | MOVE | Movano Inc. | Cullinan Brian | Dir | P - Purchase | $0.00 | +44,000 | 260,070 | +20% | +$0 | |||||
| D | 2024-04-02 | MOVE | Movano Inc. | Fairbairn Emily | Dir | P - Purchase | $0.00 | +4,690,000 | 5,916,999 | +382% | +$0 | |||||
| D | 2024-04-02 | MOVE | Movano Inc. | Mastrototaro John | CEO | P - Purchase | $0.00 | +176,500 | 291,642 | +153% | +$0 | |||||
2024-04-02 | BFLY | Butterfly Network, Inc. | Stoica Andrei G | CTO | S - Sale | $1.00 | -1,778 | 1,497,558 | 0% | -$1,782 | ||||||
| A | 2024-04-01 | INSP | Inspire Medical Systems, Inc. | Herbert Timothy P. | CEO, Pres | S - Sale | $205.09 | -40,000 | 306,737 | -12% | -$8,203,581 | |||||
2024-04-01 | SLNO | Soleno Therapeutics Inc | Yen Kristen | See Remarks | S - Sale | $41.34 | -2,218 | 23,422 | -9% | -$91,694 | ||||||
2024-04-01 | SLNO | Soleno Therapeutics Inc | Mackaness James H | CFO | S - Sale | $41.34 | -5,175 | 62,953 | -8% | -$213,937 | ||||||
2024-04-01 | SLNO | Soleno Therapeutics Inc | Hirano Patricia C | See Remarks | S - Sale | $41.34 | -2,218 | 50,924 | -4% | -$91,694 | ||||||
2024-04-01 | SLNO | Soleno Therapeutics Inc | Anish Bhatnagar | CEO | S - Sale | $41.34 | -18,980 | 152,790 | -11% | -$784,645 | ||||||
2024-04-02 | GKOS | Glaukos Corp | Thurman Alex R. | SVP, CFO | S - Sale | $90.37 | -474 | 54,916 | -1% | -$42,835 | ||||||
| D | 2024-04-03 | NXT | Nextracker Inc. | Schlesinger Leah | GC, Ch Eth, Compl Off'r, Sec | S - Sale+OE | $51.91 | -2,149 | 11,910 | -15% | -$111,555 | |||||
| D | 2024-04-02 | NXT | Nextracker Inc. | Miller Nicholas Marco | COO | S - Sale+OE | $52.67 | -8,355 | 11,114 | -43% | -$440,024 | |||||
2024-04-01 | INSP | Inspire Medical Systems, Inc. | Herbert Timothy P. | CEO, Pres | S - Sale | $205.09 | -40,000 | 306,737 | -12% | -$8,203,581 | ||||||
2024-04-01 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $217.07 | -600 | 64,281 | -1% | -$130,242 | ||||||
2024-04-01 | PEN | Penumbra Inc | Kassing Don W. | Dir | S - Sale | $223.18 | -170 | 9,675 | -2% | -$37,941 | ||||||
2024-04-01 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $17.65 | -4,000 | 65,843 | -6% | -$70,600 | ||||||
| D | 2024-04-01 | INSP | Inspire Medical Systems, Inc. | Griffin Jerry C | Dir | S - Sale+OE | $213.99 | -32 | 10,900 | 0% | -$6,848 | |||||
2024-04-01 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.15 | +8,292 | 15,223,437 | 0% | +$9,499 | ||||||
2024-04-01 | ATRC | Atricure, Inc. | Noznesky Justin J | Chief Mktg, Strategy Officer | S - Sale | $30.39 | -1,500 | 72,784 | -2% | -$45,585 | ||||||
| D | 2024-04-01 | BSX | Boston Scientific Corp | Sorenson John Bradley | EVP, Global Operations | S - Sale+OE | $69.30 | -16,351 | 50,638 | -24% | -$1,133,069 | |||||
| D | 2024-04-01 | BSX | Boston Scientific Corp | Carruthers Wendy | EVP, HR | S - Sale+OE | $68.42 | -6,983 | 51,068 | -12% | -$477,777 | |||||
| D | 2024-04-01 | TMDX | Transmedics Group, Inc. | Gordon Stephen | CFO | S - Sale+OE | $74.01 | -15,000 | 23,299 | -39% | -$1,110,150 | |||||
| D | 2024-03-30 | TRNS | Transcat Inc | Rudow Lee D. | Pres, CEO | S - Sale+OE | $111.43 | -2,373 | 103,688 | -2% | -$264,423 | |||||
2024-04-01 | COHR | Coherent Corp. | Bashaw Walter Robert II | Pres | S - Sale | $60.44 | -4,375 | 109,889 | -4% | -$264,414 | ||||||
2024-04-01 | RXST | Rxsight, Inc. | Thunen Shelley B | CFO | S - Sale | $49.90 | -20,000 | 22,093 | -48% | -$997,946 | ||||||
| D | 2024-04-01 | QTRX | Quanterix Corp | Olson Laurie J | Dir | S - Sale+OE | $23.50 | -1,000 | 15,238 | -6% | -$23,500 | |||||
2024-04-01 | MKSI | Mks Instruments Inc | Mora Elizabeth | Dir | S - Sale | $133.00 | -250 | 16,862 | -1% | -$33,250 | ||||||
| D | 2024-04-01 | EW | Edwards Lifesciences Corp | Ullem Scott B. | CVP, CFO | S - Sale+OE | $94.89 | -7,255 | 285,392 | -2% | -$688,423 | |||||
2022-11-15 | TMCI | Treace Medical Concepts, Inc. | Treace James T | Dir | S - Sale | $20.29 | -50,000 | 1,592,624 | -3% | -$1,014,692 | ||||||
2024-03-28 | DXCM | Dexcom Inc | Brown Michael Jon | EVP GC | S - Sale | $140.04 | -2,624 | 68,682 | -4% | -$367,472 | ||||||
2024-03-27 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $17.99 | -454 | 319,682 | 0% | -$8,167 | ||||||
2024-03-27 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $17.99 | -515 | 139,644 | 0% | -$9,265 | ||||||
2024-03-27 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $17.99 | -395 | 159,145 | 0% | -$7,106 | ||||||
2024-03-26 | KEYS | Keysight Technologies, Inc. | Narayanan Kailash | SVP | S - Sale | $152.88 | -4,300 | 29,156 | -13% | -$657,384 | ||||||
2024-03-26 | KLAC | Kla Corp | Higgins Bren D. | EVP, CFO | S - Sale | $705.04 | -7,018 | 32,375 | -18% | -$4,947,971 | ||||||
2024-03-27 | KEQU | Kewaunee Scientific Corp /de/ | Ranade Mandar | VP-Information Technology | S - Sale | $33.10 | -400 | 8,775 | -4% | -$13,240 | ||||||
| D | 2024-03-26 | SWAV | Shockwave Medical, Inc. | Francis Laura | Dir | S - Sale+OE | $300.00 | -1,500 | 4,784 | -24% | -$450,000 | |||||
2024-03-26 | SWAV | Shockwave Medical, Inc. | Zacharias Isaac | Pres, CCO | S - Sale | $287.67 | -4,000 | 56,818 | -7% | -$1,150,680 | ||||||
2024-03-26 | SONX | Sonendo, Inc. | Chen Roy T | Chief Talent Officer | S - Sale | $0.10 | -2,625 | 243,061 | -1% | -$274 | ||||||
2024-03-26 | SONX | Sonendo, Inc. | Bergheim Bjarne | Pres, CEO | S - Sale | $0.10 | -11,493 | 1,934,139 | -1% | -$1,199 | ||||||
| DM | 2024-03-25 | LHX | L3Harris Technologies, Inc. /de/ | Kubasik Christopher E | Chair, CEO | S - Sale+OE | $212.18 | -46,258 | 159,222 | -23% | -$9,814,933 | |||||
2024-03-25 | BFLY | Butterfly Network, Inc. | Stoica Andrei G | CTO | S - Sale | $1.03 | -3,298 | 1,499,336 | 0% | -$3,380 | ||||||
2024-03-26 | AME | Ametek Inc/ | Kohlhagen Steven W | Dir | S - Sale | $182.22 | -1,365 | 27,719 | -5% | -$248,728 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |